Infertility after long-acting paliperidone palmitate treatment: a case report

被引:0
作者
Ugur, Kerim [1 ]
Yildiz, Sevler [2 ]
机构
[1] Malatya Egitim & Arastirma Hastanesi, Psikiyatri Bolumu, Malatya, Turkey
[2] Tunceli Devlet Hastanesi, Psikiyatri Bolumu, Tunceli, Turkey
来源
KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY | 2020年 / 23卷 / 02期
关键词
Paliperidone; hiperprolactinemia; infertility; HYPERPROLACTINEMIA; ARIPIPRAZOLE;
D O I
10.5505/kpd.2020.94803
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Hyperprolactinemia is a common side effect of antipsychotic treatments. Conventional antipsychotics increase prolactin secretion due to their strong D2 receptor antagonism and long-term dependence on the receptor. Among atypical antipsychotics, risperidone and amisulpride are known to increase prolactin levels as typical antipsychotics. 9-OH risperidone (paliperidone), the active metabolite of risperidone; due to its similar receptor effect profile, it may cause prolactin elevation. Hyperprolactinemia may occur due to the use of paliperidone palmitate. Hyperprolactinemia can lead to galactorrhea, amenorrhea, sexual dysfunction, gynecomastia, hirsutism, and infertility. In patients with hyperprolactinemia, other antipsychotics may be used or aripiprazole may be added to the treatment. In this study, we aimed to present a patient who had severe benefit from long- acting antipsychotic treatment of paliperidone palmitate, but developed hyperprolactinemia during follow-up and the change in prolactin levels back to normal after changing the treatment to long-acting aripiprazole.national emergency transplant list.
引用
收藏
页码:236 / 238
页数:3
相关论文
共 11 条
[1]  
Broekhof R, 2012, GEN HOSP PSYCHIAT, V34, P209
[2]  
Bulut SD, 2015, CURRENT APPROACHES P, V7, P109
[3]   Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management [J].
Haddad, PM ;
Wieck, A .
DRUGS, 2004, 64 (20) :2291-2314
[4]   Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone [J].
Kinon, BJ ;
Gilmore, JA ;
Liu, H ;
Halbreich, UM .
PSYCHONEUROENDOCRINOLOGY, 2003, 28 :55-68
[5]   What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? [J].
Knegtering, H ;
van der Moolen, AEGM ;
Castelein, S ;
Kluiter, H ;
van den Bosch, RJ .
PSYCHONEUROENDOCRINOLOGY, 2003, 28 :109-123
[6]   Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: A pilot study [J].
Lee, Bun-Hee ;
Kim, Yong-Ku ;
Park, Sun-Hwa .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (04) :714-717
[7]   Hyperprolactinemia associated with psychotropics-a review [J].
Madhusoodanan, Subramoniam ;
Parida, Suprit ;
Jimenez, Carolina .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (04) :281-297
[8]   Using aripiprazole to attenuate paliperidone-induced hyperprolactinemia [J].
Rocha, Fabio Lopes ;
Hara, Claudia ;
Ramos, Melissa Guarieiro .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (06) :1153-1154
[9]   Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors [J].
Tadori, Yoshihiro ;
Forbes, Robert A. ;
McQuade, Robert. D. ;
Kikuchi, Tetsuro .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 597 (1-3) :27-33
[10]   Preliminary Report A Naturalistic Study of the Effect of Aripiprazole Addition on Risperidone-Related Hyperprolactinemia in Patients Treated With Risperidone Long-Acting Injection [J].
van Kooten, Marcel ;
Arends, Johannes ;
Cohen, Dan .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (01) :126-128